CD8A and neoplasm: ELISpot results showed that both CD8+ and CD4+ T cells isolated from S100 plus αTim-3-treated mice exhibited a much better ability to initiate the production of IFN-γ than T cells isolated from S100-treated mice or naive mice when incubated with DCs and tumor cell debris.